PROT# H8K-MC-JZAO: A Randomized Phase 3 Study of Tasisulam Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle vs. Paclitaxel as Second-Line Treatment in Patients with Metastatic Melanoma
- Kuzel, Timothy Michael (PD/PI)
Project: Research project